Results 161 to 170 of about 19,502 (213)

Nitazoxanide Exhibits Schistosomicidal Activity Against Schistosomula and Adult Schistosoma mansoni and Influences Praziquantel-Associated Outcomes. [PDF]

Acta Parasitol
Da Costa CJ, Gama JEM, Silva AJM, Saraiva KLA, Peixoto CA, de Araújo RE, Filho CALM, Albuquerque GHA, Moura DMN, De Oliveira SA.   +9 more
europepmc   +1 more source

Access to praziquantel in Italy: persistent gaps and ongoing responses amid a Europe-wide shortage. [PDF]

Infect Dis Poverty
Marrone R, Camponi C, Cammarata S, Di Giorgio D, Nisticò RG, Napoli C.   +5 more
europepmc   +1 more source

Conus medullaris schistosomiasis, presenting as acute conus-cauda equina syndrome in a pediatric patient: a case report. [PDF]

J Med Case Rep
Alfin DJ, Shilong DJ, Bot GM, Innocent E, Akpa PO, Bakwa ND, Othman IA.   +6 more
europepmc   +1 more source

The therapeutic potential of green synthesized zinc oxide nanoparticles in murine schistosomiasis. [PDF]

Parasites Hosts Dis
El-Kady AM, Wakid MH, Mohamed K, Alhazmi A, Al-Megrin WA, Elshazly H, Sayed E, Spears MW, Elshabrawy HA, Fadel EF, Khodary M, Hassan SME.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Praziquantel Resistance

Expert Opinion on Drug Discovery, 2007
Results from infected patients, not cured by multiple doses of praziquantel (PZQ), have been reported from different geographic locations, suggesting that resistance to the drug may be present. This has been coupled with several in vivo (e.g., studies on mice infected with 'resistant isolates') and in vitro tests (e.g., direct application and ...
Sanaa Botros
exaly   +3 more sources

Praziquantel

Parasitology Research, 2003
Praziquantel is the drug of choice for the treatment of all forms of schistosomiasis. This review summarizes the main features of the drug, with special attention being given to those aspects that may be of interest to the practicing physician. After a brief mention of the history, the chemistry, the major available brands and their costs, doses and ...
Donato, Cioli, Livia, Pica-Mattoccia
openaire   +4 more sources

Determination of ED50 Values for Praziquantel in Praziquantel-Resistant and -Susceptible Schistosoma mansoni Isolates

International Journal for Parasitology, 2004
The dose of praziquantel required to kill 50% of adult worms in vivo (i.e. the ED50) was estimated for nine different isolates of Schistosoma mansoni in infected mice. Four of the isolates were selected because they had not knowingly been in contact with
Michael J. Doenhoff, Sayed Seif el-Din, Sanaa Botros   +2 more
exaly   +1 more source

Schistosomiasis Control: Praziquantel Forever?

Molecular and Biochemical Parasitology, 2014
Since no vaccine exists against schistosomiasis and the molluscs acting as intermediate hosts are not easy to attack, chemotherapy is the main approach for schistosomiasis control. Praziquantel is currently the only available antischistosomal drug and it
Alessandra Guidi, Donato Cioli, Livia Pica-Mattoccia   +2 more
exaly   +2 more sources

Schistosomiasis and Praziquantel

Annals of Internal Medicine, 1984
Excerpt To the editor: Last year, in commenting on a review article on praziquantel published in your journal (1), we reported excellent results obtained by treatingSchistosoma haematobiuminfection...
Z, Farid, B, Trabolsi, M, Stek
openaire   +2 more sources